Overview

The Application of Zishen Yutai Pill in Aged Women Undergoing IVF-ET

Status:
Unknown status
Trial end date:
2020-12-31
Target enrollment:
0
Participant gender:
Female
Summary
To explore the application of Zishen Yutai Pill in controlled ovarian stimulation and effect on pregnancy outcome in aged women undergoing in vitro fertilization-embryo transfer.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Treatments:
Tin Fluorides
Criteria
Inclusion Criteria:

- infertile women aged ≥35 and ≤42 years;

- intend to undergo IVF-ET (long or antagonist protocol);

- BMI<28kg/m2;

- bilateral ovaries exist;

- patients who voluntarily signed the informed consent and agreed to be followed up as
required by the study protocol.

Exclusion Criteria:

- repeated implantation failure (previous three times or more IVF/ICSI-ET failure);

- adenomyosis, uterine line constricted by uterine fibroid;

- untreated bilateral hydrosalpinx;

- endometrial diseases that have not been cured ;

- known diseases that are not suitable for undergoing assisted reproductive technology
or at the present not suitable for pregnancy;

- patients who have taken traditional Chinese medicine or Chinese patent medicine for
infertility treatment in the last month(30 days).

Exit Criteria:

- subjects who have adverse events cannot be tolerated;

- severe breach of the protocol;

- for subjects who exit due to personal or unpredictable reasons, please describe
specific details;

- subjects considered inappropriate to continue to participate in the study for other
medical reasons.